We investigated the effects of leptin receptor gene 3'-untranslated region (3'-UTR) polymorphism on clinical and metabolic parameters in 221 young Japanese men aged 21 to 28 years. The polymerase chain reaction-restriction fragment length polymorphism method was used to identify a pentanucleotide (CTTTA) insertion in 3'-UTR of the leptin receptor gene. Body mass index, blood pressure, plasma glucose, insulin, leptin, total cholesterol, high-density lipoprotein (HDL)-cholesterol, low-density lipoprotein (LDL)-cholesterol, triglycerides, free fatty acids, uric acid, apolipoprotein A-I (apoA-I), and cholesteryl-ester transfer protein levels were measured. There was only 1 homozygote and 38 heterozygotes for the 3'-UTR insertion allele among the 221 subjects. The insertion allele frequency was 0.090. Plasma HDL-cholesterol and apoA-I levels were significantly lower (p = 0.015 and p = 0.032 by Mann-Whitney U test, respectively) in homozygous or heterozygous carriers of the insertion allele than in subjects homozygous for the normal allele. There were no differences in other parameters measured. Furthermore, when the subjects were divided into three groups according to HDL-cholesterol level, the percentage of insertion allele-positive subjects was significantly lower in the highest HDL-cholesterol group (χ 2 = 8.42, p = 0.015). These findings suggest that serum HDL-cholesterol and apoA-I levels are influenced by the leptin receptor gene 3'-UTR polymorphism in young Japanese men. J Atheroscler Thromb, 2004; 11: 73-78.
Introduction
Obesity, diabetes mellitus, hypertension, and dyslipidemia are all risk factors for atherosclerotic diseases, based on insulin resistance and/or the resultant hyperinsulinemia (1) (2) (3) (4) . Leptin, the product of obese (ob) gene, is secreted by adipocytes and acts as a circulating satiety signal in the regulation of body weight in mice (5) (6) (7) . Recently, many other roles of leptin have been revealed, such as roles in glucose metabolism (8) , the reproductive system (9) , and the hematopoietic system (10).
Leptin acts via binding to leptin receptors that are expressed in a variety of tissues including the brain (11) , pancreas (12) , liver (13) , ovary (14) , and hematopoietic stem cells (10) . It is reported that leptin reverses insulin resistance and hepatic steatosis in patients with lipodystrophy (15) . Oksanen et al. (16) demonstrated a pentanucleotide polymorphism of the 3'-untranslated region (3'-UTR) of the leptin receptor gene and studied its relationship with metabolic profiles in severely obese subjects (present or past BMI ≥ 40 kg/m 2 ). They reported that the frequency of the insertion allele in lean controls (BMI < 25 kg/m 2 ) did not differ from that in the obese group (0.120 vs 0.124). However, the serum insulin level was found to be lower in heterozygous carriers of the insertion allele in obese individuals (16) .
Although other studies have demonstrated that subjects with the insertion allele of the leptin receptor gene 3'-UTR have lower serum insulin levels in obese Caucasians (17) (18) (19) , no studies thus far have revealed positive results as to the effects of this polymorphism on blood pressure or lipid profile. Because leptin has been shown to ameliorate insulin resistance in animals (20, 21) and in humans (15), we investigated the effects of 3'-UTR polymorphism of the leptin receptor gene on BMI, blood pressure, plasma glucose and lipid profiles in young healthy Japanese men.
Subjects and Methods
The present study included 221 male university students aged 21 to 28 years who received an annual health checkup. Subjects with diabetes mellitus, endocrine disease, significant renal or hepatic disease and those receiving antihypertensive agents, systemic corticosteroids, or lipid-lowering medication were excluded. This study was carried out in accordance with the Declaration of Helsinki (1981) of the World Medical Association, and the study protocol was approved by the Ethical Review Committee of Keio University School of Medicine, Tokyo, Japan. Informed consent was obtained from each subject after full explanation of the purpose, nature, and risk of all procedures used.
Measurements
Height, body weight, systolic blood pressure (SBP), and diastolic blood pressure (DBP) were measured. SBP and DBP were measured with an automatic electronic sphygmomanometer (BP-103i II, Nippon Colin, Komaki, Japan), twice in the sitting position after resting for at least 5 min, as described previously (22, 23) . Plasma glucose, serum lipids, etc. were assayed in all subjects using peripheral blood samples obtained after an overnight fast. Plasma glucose was determined by the glucose oxidase method. Total cholesterol, triglycerides (TG), high-density lipoprotein (HDL)-cholesterol, low-density lipoprotein (LDL)-cholesterol, free fatty acids (FFA), and uric acid were measured by enzymatic assays (Hitachi autoanalyzer, Hitachi, Tokyo, Japan). Serum insulin and leptin concentrations were measured with commercially available kits (Shionogi Co., Tokyo, Japan, and Linco Research Inc., St. Charles, Missouri, USA, respectively) based on radioimmunoassays, as described previously (22, 23) . Apolipoprotein-AI (apoA-I) was measured by turbidimetric immunoassay, and the cholesteryl-ester transfer protein (CETP) level was measured by enzyme-linked immunosorbent assay in 111 subjects whose serum sample was available. The insulin resistance index was assessed by homeostasis model assessment (HOMA-IR) (24, 25) .
Sample collection and polymorphism analysis
A 5-mL sample of venous blood was collected in a vacutainer containing EDTA. Genomic DNA was extracted from the peripheral white blood cell fraction by the standard method. Approximately 100 ng of extracted DNA was used as a template. A common polymorphism of 3'-UTR of the leptin receptor gene, insertion of pentanucleotide (CTTTA) (16) , was detected as follows. The primers used were 5'-ATA ATG GGT AAT ATA AAG TGT AAT AGA GTA-3' and 5'-AGA GAA CAA ACA GAC AAC ATT-3'. The reaction was performed in a final volume of 20 µl containing 2 mmol/l MgCl2, 0.2 mmol/l of each dNTP, 5 pmol of each primer, and 0.5U Taq DNA polymerase (Takara, Tokyo, Japan). DNA was denatured for 2 minutes at 94°C, and amplified for 35 cycles (1 minute each) at 94°C, 60°C, and 72°C. After the cycles, there was a 4-minute extension at 72°C.
Polymerase chain reaction (PCR) products were digested with a 10-fold excess of restriction enzyme Afa I (Takara) at 37°C for 3 hours. They were then electrophoresed on 3% agarose gel with 0.5x Tris-borate-EDTA buffer. Afa I restriction fragment length polymorphism was detected by ethidium bromide staining, which revealed a 2-allele polymorphism that produced bands of different sizes: a 114-bp fragment corresponding to the deletion (normal) allele, and a 119-bp fragment corresponding to the insertion allele.
Statistical analysis
All statistical analyses were performed using the StatView  program for Macintosh (version 5.0-J, SAS Institute, Cary, North Carolina). All data are expressed as the mean ± SEM. We used the Mann-Whitney U test for comparison of quantitative variables (Table 1 ) and the χ 2 test for comparison of proportions (Table 2) . A p value of less than 0.05 was considered statistically significant.
Results
The genotype distribution of the leptin receptor gene 3'-UTR was governed by the Hardy-Weinberg law in this study. As shown in Table 1 , 38 subjects (17.2%) were heterozygous and only one subject (0.5%) was homozygous for the pentanucleotide insertion allele. Therefore, we divided the subjects into two groups according to the absence or presence of the insertion allele. Both HDLcholesterol and apoA-I levels were significantly lower in the insertion allele-positive group (del/ins or ins/ins) (p = 0.015 and p = 0.032 by the Mann-Whitney U test, respectively). There were no differences in other parameters measured including BMI. The characteristics of the one subject homozygous for the insertion allele were not unusual; BMI was 21.0 kg/m 2 , glucose 89 mg/dl, HDLcholesterol 56 mg/dl, LDL-cholesterol 104 mg/dl, and the apoA-I level was not measured. As shown in Table 2 , we divided the subjects into three groups (tertiles) according to HDL-cholesterol level: low (HDL-cholesterol ≤ 51 mg/dl), middle (52 ≤ HDL-cholesterol ≤ 60 mg/dl), and high (HDL-cholesterol ≥ 61 mg/dl). In these three groups, 17 (23.0%), 17 (22.7%), and 5 subjects (6.9%) were insertion allele-positive, respectively, and this difference was statistically significant (χ 2 = 8.42, p = 0.015). The insertion allele frequency was also significantly lower in the highest HDL-cholesterol group (χ 2 = 8.10, p = 0.018). There was no significant correlation between age and HDL-cholesterol in this study population (r = -0.083, p = 0.208). However, HDL-cholesterol was negatively correlated with BMI (r = -0.245, p = 0.0002), which was consistent with our findings in other general population cohorts of different age groups (22, 23) . When the subjects were divided into three groups according to BMI-adjusted HDL-cholesterol levels (Table 3) , differences in the genotype and allele frequencies of the leptin receptor gene 3'-UTR became more significant (p = 0.001 and p = 0.004, respectively): insertion allele-positive subjects were less frequent in the highest HDL-cholesterol group.
Discussion
To our knowledge, this is the first study to suggest an association between leptin receptor gene polymorphism and HDL-cholesterol level. In this study, plasma HDLcholesterol and apoA-I levels were significantly lower in the insertion allele-positive group than in subjects homozygous for the deletion (normal) allele. However, the effects of this insertion/deletion polymorphism may not be so strong, because one homozygote for the insertion allele in this study had normal metabolic features. When the subjects were divided into three groups according to apoA-I levels, we could not observe a significant difference in genotype or allele frequency (data not shown), although the number of subjects whose serum was available for determination of apoA-I level was half the total (n = 111) in this study.
In mice, Silver et al. (26) suggested that leptin may play a physiological role in regulating HDL-cholesterol and apolipoprotein levels. They found that ob/ob mice with a defective leptin receptor have impaired hepatic HDL catabolism that leads to an elevated circulating HDL-cholesterol level (27) . Furthermore, they showed that hepatocytes from ob/ob mice decrease binding, uptake, and degradation of HDL-apolipoproteins, as well as markedly decrease recycling of HDL apolipoproteins through the endosomal recycling compartment (26) . All of these defects were reversed by leptin administration. They suggested that a receptor other than scavenger receptor B-I exists for the uptake of HDL apolipoproteins (26) .
In clinical studies, Oksanen et al. (16) first demonstrated this pentanucleotide polymorphism of the leptin receptor gene, and studied its relationship to metabolic profiles including the lipid profile in severely obese subjects. Although they did not refer to the metabolic profiles of lean subjects, they compared the levels of total cholesterol, HDL-cholesterol, and TG according to ins/del genotypes in severely obese subjects. However, they found no significant association. With respect to their subjects, however, the age range was wide, from 18 to 60 years (mean age: 46 ± 9 years). Both sexes were included, and some of them had type 2 diabetes or hypertension. In the present study, the subjects were non-diabetic young men not on any medication, so that the impact of leptin receptor genotype would be clearer. The mechanisms underlying the relationship between the leptin receptor gene 3'-UTR polymorphism and HDLcholesterol level are unclear and remain to be elucidated. It has been reported, however, that the long-form leptin receptor (ObRb) is expressed in human liver (28, 29) . Because the uptake of HDL-apolipoproteins is regulated by leptin in mice (26, 27) , genetic alterations of the leptin receptor might be responsible for the change in the rate of catabolism of HDL-cholesterol. It is possible that the presence of a pentanucleotide insertion generates a sequence that putatively forms a stem-loop motif in the receptor mRNA (16) . Stem-loop sequences can affect mRNA stability, possibly because these motifs bind to regulatory proteins, which in turn could affect the rate of degeneration and/or translation of mRNA (30, 31) . It is unfortunate that there have been no functional studies on the effects of this 3'-UTR polymorphism. Although stem-loop sequences usually de-stabilize mRNA (30, 31) , it is unclear whether those in 3'-UTR of the leptin receptor gene, which would be formed by the pentanucleotide insertion allele, might stabilize or de-stabilize the mRNA. Oksanen et al. (16) hypothesized that this polymorphism might stabilize the mRNA level of the leptin receptor.
Because this study consisted of an annual health checkup for university students, we have no data concerning their lifestyle, such as smoking and physical activity. The importance of apo C-III T-455C polymorphism has also been indicated (32, 33) , which reportedly affects apo C-III and TG levels and the risk of coronary artery disease (33) . Unfortunately, we were not able to measure apo C-III levels in this study. Further studies will be needed to clarify the significance of the leptin receptor gene 3'-UTR polymorphism in different age, sex, and ethnic groups in combination with other variant alleles. In conclusion, it is suggested that serum HDL-cholesterol and apoA-I levels are influenced by the leptin receptor gene 3'-UTR polymorphism in young Japanese men.
